ResearcherActive in the last 2 years
Lisa A. Ford
Matched on ORCID iD 0000-0002-6207-8108; OpenAlex author ID A5062945252. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2025: 3 papers · 2026: 2 papers
Papers 5
- Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.08.034↗
- The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective S… Co-author DOI 10.3390/jcm15197355↗
- A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals. Co-author DOI 10.3390/cancers17111866↗
- Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol32110638↗
- Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/diagnostics15243177↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Norma Alonzo Palma · 5 shared papers, 2025–2026 · strength 1.27
- Paper Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics15243177↗
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Ad… DOI 10.3390/curroncol32110638↗
- Thomas Charles King · 5 shared papers, 2025–2026 · strength 1.27
- Paper Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.3390/diagnostics15243177↗
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Ad… DOI 10.3390/curroncol32110638↗
- Randall E. Brand · 4 shared papers, 2025–2026 · strength 0.96
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Ad… DOI 10.3390/curroncol32110638↗
- Paper A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individua… DOI 10.3390/cancers17111866↗
- Erkut Hasan Borazanci · 3 shared papers, 2025–2026 · strength 0.73
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Ad… DOI 10.3390/curroncol32110638↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Patricio Marcelo Polanco · 2 shared papers, 2025–2026 · strength 0.51
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Ad… DOI 10.3390/curroncol32110638↗
- Rosalie C. Sears · 2 shared papers, 2026 · strength 0.49
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Sonia S. Kupfer · 2 shared papers, 2026 · strength 0.49
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Walter Gwang-Up Park · 2 shared papers, 2026 · strength 0.49
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Salvatore Paiella · 2 shared papers, 2026 · strength 0.49
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Fay Kastrinos · 2 shared papers, 2026 · strength 0.49
- Paper The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma fr… DOI 10.3390/jcm15197355↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Jose Gilberto Trevino · 2 shared papers, 2025–2026 · strength 0.47
- Paper Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Ad… DOI 10.3390/curroncol32110638↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Bryson W. Katona · 2 shared papers, 2025–2026 · strength 0.45
- Paper A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individua… DOI 10.3390/cancers17111866↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Diane M. Simeone · 2 shared papers, 2025–2026 · strength 0.45
- Paper A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individua… DOI 10.3390/cancers17111866↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Aimee Lee Lucas · 2 shared papers, 2025–2026 · strength 0.45
- Paper A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individua… DOI 10.3390/cancers17111866↗
- Paper Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.08.034↗
- Robyn Pescatore · 1 shared paper, 2025 · strength 0.30
- Tamas Gonda · 1 shared paper, 2026 · strength 0.26
- Tamas A. Gonda · 1 shared paper, 2025 · strength 0.25
- Evan Scott Glazer · 1 shared paper, 2025 · strength 0.25
- Alcibiade Athanasiou · 1 shared paper, 2025 · strength 0.23
- Ralph Schiess · 1 shared paper, 2025 · strength 0.23
- Jessica N. Everett · 1 shared paper, 2026 · strength 0.22
- Eli Marie Grindedal · 1 shared paper, 2026 · strength 0.22
- Raymond Couric Wadlow · 1 shared paper, 2026 · strength 0.22
- George Zogopoulos · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.